• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Autoimmun Rev . Autoimmunity roots of the thrombotic events after COVID-19 vaccination

tetano

Editor, Senior Moderator
Autoimmun Rev


. 2021 Sep 8;102941.
doi: 10.1016/j.autrev.2021.102941. Online ahead of print.
Autoimmunity roots of the thrombotic events after COVID-19 vaccination


Fatma Elrashdy[SUP] 1 [/SUP], Murtaza M Tambuwala[SUP] 2 [/SUP], Sk Sarif Hassan[SUP] 3 [/SUP], Parise Adadi[SUP] 4 [/SUP], Murat Seyran[SUP] 5 [/SUP], Tarek Mohamed Abd El-Aziz[SUP] 6 [/SUP], Nima Rezaei[SUP] 7 [/SUP], Amos Lal[SUP] 8 [/SUP], Alaa A A Aljabali[SUP] 9 [/SUP], Ramesh Kandimalla[SUP] 10 [/SUP], Nicolas G Bazan[SUP] 11 [/SUP], Gajendra Kumar Azad[SUP] 12 [/SUP], Samendra P Sherchan[SUP] 13 [/SUP], Pabitra Pal Choudhury[SUP] 14 [/SUP], Ángel Serrano-Aroca[SUP] 15 [/SUP], Kazuo Takayama[SUP] 16 [/SUP], Gaurav Chauhan[SUP] 17 [/SUP], Damiano Pizzol[SUP] 18 [/SUP], Debmalya Barh[SUP] 19 [/SUP], Pritam Kumar Panda[SUP] 20 [/SUP], Yogendra K Mishra[SUP] 21 [/SUP], Giorgio Palù[SUP] 22 [/SUP], Kenneth Lundstrom[SUP] 23 [/SUP], Elrashdy M Redwan[SUP] 24 [/SUP], Vladimir N Uversky[SUP] 25 [/SUP]



Affiliations

Abstract

Although vaccination represents the most promising way to stop or contain the coronavirus disease 2019 (COVID-19) pandemic and safety and effectiveness of available vaccines were proven, a small number of individuals who received anti-SARS-CoV-2 vaccines developed a prothrombotic syndrome. Vaccine-induced immune thrombotic thrombocytopenia (VITT) can be triggered by the adenoviral vector-based vaccine, whereas lipid nanoparticle-mRNA-based vaccines can induce rare cases of deep vein thrombosis (DVT). Although the main pathogenic mechanisms behind this rare phenomenon have not yet been identified, both host and vaccine factors might be involved, with pathology at least in part being related to the vaccine-triggered autoimmune reaction. In this review, we are considering some aspects related to pathogenesis, major risk factors, as well as peculiarities of diagnosis and treatment of this rare condition.

Keywords: Adenoviral vector-based vaccine; Autoimmune reaction; COVID-19; Lipid nanoparticle-mRNA-based vaccine; Vaccine-induced immune thrombotic thrombocytopenia.
 
Back
Top Bottom